Exome Asset Management LLC
- SEC CIK
- 0002011932
- 最新申報
- 2026/8/14
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/15 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 55
- 較 2025 年第 1 季 +6
- 總值
- $1.21 億
- 較 2025 年第 1 季 +$963.3 萬 (+8.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| iShares Tr464287954 | PUT | 200,000 | $735.2 萬 | 6.1% | +200,000 | 新進 | – |
| BBIOBridgeBio Pharma, Inc. | COM | 155,533 | $671.6 萬 | 5.5% | −9,963−6.0% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 98,182 | $510.9 萬 | 4.2% | −29,000−22.8% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 3,414,377 | $481.4 萬 | 4.0% | +198,920+6.2% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 121,116 | $478.5 萬 | 3.9% | −14,500−10.7% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 27,000 | $475.2 萬 | 3.9% | +27,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 533,647 | $383.2 萬 | 3.2% | −88,031−14.2% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 115,817 | $382.7 萬 | 3.2% | +12,334+11.9% | 加碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 397,846 | $369.6 萬 | 3.0% | +103,000+34.9% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 4,673 | $364.3 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 41,641 | $348.9 萬 | 2.9% | −1,800−4.1% | 減碼 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 6,358 | $345.5 萬 | 2.8% | 00.0% | 不變 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 61,356 | $324.9 萬 | 2.7% | −300−0.5% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 18,650 | $315.1 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 444,949 | $306.1 萬 | 2.5% | −244,188−35.4% | 減碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 84,339 | $298.7 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 308,298 | $288.7 萬 | 2.4% | −28,900−8.6% | 減碼 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 599,900 | $249.0 萬 | 2.1% | +599,900 | 新進 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 59,002 | $248.1 萬 | 2.0% | +59,002 | 新進 | 歷史 |
| PENPenumbra Inc | COM | 9,000 | $231.0 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 233,426 | $229.2 萬 | 1.9% | −120,456−34.0% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 153,278 | $226.9 萬 | 1.9% | +35,261+29.9% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 166,944 | $219.4 萬 | 1.8% | +24,200+17.0% | 加碼 | 歷史 |
| Nektar Therapeutics640268906 | CALL | 75,000 | $193.8 萬 | 1.6% | +75,000 | 新進 | – |
| WAYWaystar Holding Corp. | COM | 46,900 | $191.7 萬 | 1.6% | +46,900 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 277,317 | $191.3 萬 | 1.6% | −12,373−4.3% | 減碼 | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 163,658 | $189.5 萬 | 1.6% | +163,658 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 195,933 | $186.5 萬 | 1.5% | −62,458−24.2% | 減碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 226,060 | $185.6 萬 | 1.5% | −179,221−44.2% | 減碼 | 歷史 |
| UHSUniversal Health Services Inc | CL B | 10,100 | $183.0 萬 | 1.5% | +10,100 | 新進 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 76,700 | $180.7 萬 | 1.5% | +76,700 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 62,700 | $180.3 萬 | 1.5% | +11,405+22.2% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 98,600 | $170.7 萬 | 1.4% | +98,600 | 新進 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 124,470 | $163.2 萬 | 1.3% | +53,032+74.2% | 加碼 | 歷史 |
| Travere Therapeutics Inc89422G907 | CALL | 110,000 | $162.8 萬 | 1.3% | +110,000 | 新進 | – |
| BCRXBiocryst Pharmaceuticals Inc | COM | 172,883 | $154.9 萬 | 1.3% | +112,283+185.3% | 加碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | 2,000,000 | $152.4 萬 | 1.3% | 00.0% | 不變 | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 73,000 | $148.6 萬 | 1.2% | +73,000 | 新進 | 歷史 |
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | 2,000,000 | $144.5 萬 | 1.2% | +2,000,000 | 新進 | – |
| GOSSGossamer Bio, Inc. | COM | 1,097,999 | $135.1 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 53,744 | $111.5 萬 | 0.9% | −49,200−47.8% | 減碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 29,100 | $103.3 萬 | 0.9% | +29,100 | 新進 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 63,076 | $72.0 萬 | 0.6% | −70,037−52.6% | 減碼 | 歷史 |
| ALVOAlvotech | ORDINARY SHARES | 78,372 | $71.5 萬 | 0.6% | −11,728−13.0% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 36,574 | $66.2 萬 | 0.5% | +36,574 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 213,544 | $59.8 萬 | 0.5% | +213,544 | 新進 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 13,100 | $56.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| YARWYarrow Bioscience, Inc. | COM | 208,970 | $34.5 萬 | 0.3% | −253,831−54.8% | 減碼 | 歷史 |
| TILInstil Bio, Inc. | COM NEW | 16,200 | $33.7 萬 | 0.3% | +16,200 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 15,000 | $33.3 萬 | 0.3% | −101,623−87.1% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 114,145 | $30.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LQDALiquidia Corp | COM NEW | 20,500 | $25.5 萬 | 0.2% | +20,500 | 新進 | 歷史 |
| ABUSArbutus Biopharma Corp | COM | 75,484 | $23.3 萬 | 0.2% | +75,484 | 新進 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 110,353 | $4.05 萬 | <0.1% | +110,353 | 新進 | 歷史 |
| Mereo Biopharma Group PLC589492957 | PUT | 14,600 | $3.96 萬 | <0.1% | +14,600 | 新進 | – |
選擇權（8 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | $393.3 萬 | – |
| AKROAkero Therapeutics, Inc. | COM | $312.6 萬 | – |
| ACADAcadia Pharmaceuticals Inc | COM | – | $201.1 萬 |
| CORCencora, Inc. | Stock | – | $179.9 萬 |
| Ultragenyx Pharmaceutical IN90400D908 | CALL | – | $136.3 萬 |
| UNHUnitedHealth Group Inc | Stock | – | $43.7 萬 |
| Altimmune Inc02155H950 | COM NEW | $41.4 萬 | – |
| Fulcrum Therapeutics Inc359616909 | CALL | – | $13.8 萬 |
2025 年第 1 季之後清倉（15 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 32,534 | $472.6 萬 | 4.2% | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 76,379 | $309.2 萬 | 2.8% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 217,294 | $292.9 萬 | 2.6% | 歷史 |
| SVRASavara Inc | COM | 836,397 | $231.7 萬 | 2.1% | 歷史 |
| GEHCGE HealthCare Technologies Inc. | Stock | 25,400 | $205.0 萬 | 1.8% | 歷史 |
| IMNMImmunome Inc. | COM | 263,841 | $177.6 萬 | 1.6% | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 6,500 | $176.9 萬 | 1.6% | 歷史 |
| RDYDr Reddys Laboratories Ltd | ADR | 117,500 | $155.0 萬 | 1.4% | 歷史 |
| NKTRNektar Therapeutics | COM | 2,232,453 | $151.8 萬 | 1.4% | 歷史 |
| ARVNArvinas, Inc. | COM | 195,295 | $137.1 萬 | 1.2% | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 163,738 | $103.0 萬 | 0.9% | 歷史 |
| BHVNBiohaven Ltd. | COM | 39,900 | $95.9 萬 | 0.9% | 歷史 |
| AKBAAkebia Therapeutics, Inc. | COM | 189,087 | $36.3 萬 | 0.3% | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 96,311 | $17.0 萬 | 0.2% | 歷史 |
| APREAprea Therapeutics, Inc. | COM NEW | 28,972 | $5.91 萬 | 0.1% | 歷史 |